アポリポプロテインエプシロン4 冠動脈性心疾患の若い男性におけるホモジゴシティ
F M van Bockxmeer1, C D Mamotte
1Department of Biochemistry, Royal Perth Hospital, Western Australia.
Lancet (London, England)
|October 10, 1992
まとめ
アポリポプロテインE (APOE) 遺伝子変異,特にエプシロン4アレルは,オーストラリアの男性における早発性心不全症に関連しています. APOE epsilon 4 のホモジゴシティは,特に若い年齢では,リスクを大幅に増加させます.
科学分野:
- 遺伝学 遺伝学とは
- 心臓病学 心臓病学
- 分子生物学は分子生物学である.
背景:
- アポリポプロテインE (APOE) は,脂質代謝において重要な役割を果たします.
- APOE遺伝子ポリモルフィズム,特にエプシロン4アレルは,様々な心血管疾患と関連しています.
研究 の 目的:
- オーストラリアの男性におけるアポリポプロテインE遺伝子ポリモルフィズムと早発性心不全性疾患との関連を調査する.
- 冠動脈血管新生手術に推薦された男性におけるAPOE遺伝子型頻度を,健康な対照群の男性と比較するために.
主な方法:
- アポリポプロテインE遺伝子ポリモルフィズムのゲノタイプ化が行われました.
- 患者 (n=91,30~50歳,血管新生手術を受けている) と健康な対照群 (n=172) の間のアレル頻度の比較.
主要な成果:
- APOEエプシロン4アレルの有意に高い罹患率は,対照群と比較して患者で観察されました.
- 40歳未満の男性で,エプシロン4アルレルのホモジゴスであった男性は,対照群と比較して16倍に増加した罹患率を示しました.
- 40~50歳の患者では,エプシロン4アレル頻度は対照群よりも60%高かった.
結論:
- APOEエプシロン4アルレルの遺伝は,男性における早発性心不全性疾患のリスクを高めるようです.
- APOE epsilon 4 アレルのホモジゴシティは,若い年齢において特に高いリスクと関連しています.
関連する概念動画
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:30Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...